Home/Filings/4/0001818382-22-000053
4//SEC Filing

Scheessele William John 4

Accession 0001818382-22-000053

CIK 0001818382other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 11:46 AM ET

Size

4.6 KB

Accession

0001818382-22-000053

Insider Transaction Report

Form 4
Period: 2022-05-24
Scheessele William John
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2022-05-24$4.72/sh+10,525$49,67810,525 total

Issuer

Humacyte, Inc.

CIK 0001818382

Entity typeother

Related Parties

1
  • filerCIK 0001879378

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 11:46 AM ET
Size
4.6 KB